• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
2011 U.S. Markets for External Radiation Therapy Product Image

2011 U.S. Markets for External Radiation Therapy

  • ID: 1230874
  • May 2011
  • Region: United States
  • 66 Pages
  • Life Science Intelligence

2011 U.S. Markets for External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for:

- High quality, granular, deeply segmented data
- Access to senior a analysts to conduct proprietary modeling and custom market simulations
- Access to useable source data for in-house customization and adoption of market models

The deliverables include:

- Initial report with most recent data available (PDF and Excel)
- Extensive access to a senior analyst for proprietary add-on analysis
- Online platform making the data useable and interactive

1. ESTABLISHED AND EMERGING TECHNOLOGIES

1.1 Features of Established Technologies
1.2 Challenges for Established Technologies

1.2.1 Conformality

1.2.2 Anoxic Tissues

1.2.2.1 Economic Factors

1.2.2.1.1 Reimbursement and National Policies and Initiatives

1.2.2.1.2 System Prices & Associated Costs

1.2.2.1.3 The Global Economy

Exhibit 1-1: External Radiation Therapy by Type
Exhibit 1-2: Advantages and Disadvantages of External Radiation Therapy Systems
Exhibit 1-3: Features of Linear Accelerator and Gamma-Ray Systems Used for External Radiation Therapy and SRS
Exhibit 1-4: Features of Particle Therapy Centers
Exhibit 1-5: Challenges Associated with Available Technologies
Exhibit 1-6: Established and Emerging Technologies

2. U.S. MARKETS FOR EXTERNAL RADIATION THERAPY

Exhibit 2-1: External Radiation Therapy, U.S. Market Forecast, 2007-2013
Exhibit 2-2: External Radiation Therapy, Supplier Shares, 2008
Exhibit 2-3: Factors Influencing the U.S. Market for Linear Accelerator & Gamma-Ray Systems from 2007-2013
Exhibit 2-4: U.S. External Radiation Therapy, Linear Accelerators & Gamma-Ray Systems, 2007-2013
Exhibit 2-5: Linear Accelerator & Gamma-Ray Systems, U.S. Shares, 2008
Exhibit 2-6: U.S. Market Forecast by Type of System, Linear Accelerator and Gamma-Ray Systems, 2007-2013
Exhibit 2-7: Linear Accelerator and Gamma-Ray Systems, 2008 & 2013
Exhibit 2-8: Impact of the Recession: Gamma-Ray Systems and Linear Accelerators, 2007-2013
Exhibit 2-9: Factors Influencing the U.S. Market for External Radiation Therapy and SRS from 2007-2013
Exhibit 2-10: External Radiation Therapy, U.S. Market Forecast by Application, 2007-2013
Exhibit 2-11: SRS and External Radiation Systems, 2008 & 2013
Exhibit 2-12: Impact of the Recession: SRS Systems, 2007-2013
Exhibit 2-13: Stereotactic Radiosurgery - U.S. Patient Volumes, 2007-2013
Exhibit 2-14: Stereotactic Radiosurgery - U.S. Patient Volumes by Type, 2007-2013
Exhibit 2-15: Stereotactic Radiosurgery - Utilization by Patient Type, 2007-2013
Exhibit 2-16: Extracranial Stereotactic Radiosurgery - U.S. Patient Volumes, 2007-2013
Exhibit 2-17: Stereotactic Radiosurgery - U.S. Procedure Volumes, 2007-2013
Exhibit 2-18: Stereotactic Radiosurgery - U.S. Procedures by Type, 2007-2013
Exhibit 2-19: Stereotactic Radiosurgery - Utilization by Procedure, 2007-2013
Exhibit 2-20: Extracranial Stereotactic Radiosurgery - U.S. Procedure Volumes, 2007-2013
Exhibit 2-21: Impact of the Recession: External Radiation Therapy Systems, 2007-2013.
Exhibit 2-22: New Cancer Cases in the U.S by Anatomical Location, 2007-2013
Exhibit 2-23: Breast, Lung and Prostate Patients Treated with External Radiation Therapy in the U.S., 2007-2013
Exhibit 2-24: Other Patients Treated with External Radiation Therapy, 2007-2013
Exhibit 2-25: External Radiation Therapy in the U.S., Breast, Lung, and Prostate Procedures, 2007-2013
Exhibit 2-26: Other External Radiation Therapy Procedures in the U.S., 2007-2013
Exhibit 2-27: Factors Influencing the U.S. Market for Proton Therapy, 2007-2013
Exhibit 2-28: Proton Therapy, U.S. Market Forecast, 2007-2013
Exhibit 2-29: Proton Therapy Systems, U.S. Supplier Shares in 2008
Exhibit 2-30: Proton Therapy, U.S. Patient Volumes, 2007-2013
Exhibit 2-31: Proton Therapy, U.S. Procedure Volumes, 2007-2013

3. MERGERS, ACQUISITIONS, AND PARTNERSHIPS

4. EMERGING COMPANIES

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos